Blinatumomab in Acute Lymphoblastic Leukemia

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1586/14737140.2016.1143778
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Potential for Bispecific T-Cell Engagers: Role of Blinatumomab in Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Correlates of Resistance and Relapse During Blinatumomab Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2017English

Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

Advances in Therapy
MedicinePharmacology
2019English

Acute Lymphoblastic Leukemia

2016English

Acute Lymphoblastic Leukemia

2020English

Acute Lymphoblastic Leukemia

English

Acute Lymphoblastic Leukemia

2009English

Acute Lymphoblastic Leukemia

2019English

Pediatric Acute Lymphoblastic Leukemia

Hematology & Transfusion International Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy